First they started brewing cannabis-infused beer, now Althea Group (ASX: AGH) is bringing cans of cannabis-based sodas to the market that will inevitably have certain consumers checking whether they’re tripping. The move is set to shake up the cannabis-based products market as a recreational product that will make a bold entry into the burgeoning US
Read More
After witnessing a cash burn of $368k in the previous quarter, Cannabis-based pharmaceutical company Althea Group (ASX: AGH) has entered cash flow positivity from its operating activities in Q1 FY24, resulting in a net cash inflow of $35,000. This achievement can be attributed to the Company’s successful cost-cutting initiatives, which have begun to yield results.
Read More
Cannabis is the most widely-used illicit drug worldwide; about 2.5% of the world, i.e. approximately 150 million people, consume cannabis, and Australia is among the top countries leading the trend. While it sounds the alarm on the concerning drug abuse problem, it also signals a profitable market for companies in the field. Cannabis-based medicine and
Read More
The cheers of the cannabis industry can be heard loud and clear as the demand for the plant continues to prop up their profits. The last few years have been huge for the industry as companies attempt to strengthen earnings by out-scaling competitors. One company hoping to come out on top is Althea Group (ASX:
Read More
Medicinal cannabis and research company Althea Group (ASX: AGH) has today announced that its Canadian subsidiary, Peak Processing, has received a binding purchase order from WeedMD Rx (A subsidiary of canadian listed company WeedMD Inc, TSX-V: WMD). The CAD$130,000 order will see Peak perform a variety of services for WeedMD, including hydrocarbon extraction of fresh-frozen
Read More
Medicinal cannabis and research company Althea Group (ASX: AGH) has become the first Australian producer of commercial cannabis products to be granted the required licenses in Germany for sales and distribution. With the licences, Althea expects their first shipment of their Australian-made medicinal cannabis extract products to take place in December 2020. The licenses were
Read More